Return Peptide Library
MBX 5765
DLevel 1 evidenceMBX 5765
Amylin analog
Basic Information
Categories
Amylin/GLP-1 dual agonist prodrug
Overview
MBX Biosciences investigational amycretin prodrug extends duration of action, enabling dual receptor activation of amylin and GLP-1.
Efficacy Rating
Research on amylin, GLP-1
Evidence Level
D-Rank
Evidence Type
No data available
Confidence
No data available
China Regulatory Status
Cosmetic Ingredient Directory
No data available
Food/Supplements
No data available
Medicine
No data available
Similar Peptide Recommendations
Disclaimer
The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.